Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Seres Therapeutics Inc (MCRB)

NASDAQ
Currency in USD
Disclaimer
0.9199
-0.0045(-0.49%)
Closed
After Hours
0.8860-0.0339(-3.6852%)

MCRB Comments

Sorry over valued zone. Not oversold.
Quickly burning its cash and also in oversold zone.
In December 2020, when SER-109 passed phase 3, the price rose to $38. Expect it to be at that price again in a month. Analysts will increase the target price after FDA approval.
They develop a new placebo... Great... Trash
excellent move.
Which 1 is moving up like this 1 tomorrow
Hopefully not another kodak
Overnight skyrocket for no reason, terrible Financials? I'd say so.
come to daddy
lets find a good entry point
shares were halted ?
several times already
nice.28.sold.
nice move.wait for more.
Sold at 21.5. I was lucky. Could be that later today it will go up again around the 25
Pop up and sell?
How come nobody has comments for the buys
good question
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.